Skip to content
Federal officials said they withdrew plans for new regulation of genetically engineered (GE) crops on U.S. wildlife refuges due to the outcry by numerous […]
How BIO’s comments affected regulations on genetically engineered crops Read More »
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand the issue clearly. In
Combatting misinformation on biotechnology in food Read More »
The 10-year-old girl was cheerful and upbeat as she spoke to a group of strangers online, but she was also disarmingly clear-eyed about the
Children with rare diseases advocate for legislation in online panel Read More »
HIV is not the death sentence that it was decades ago. Yet, there is still much work to be done in the HIV advocacy
How to break down barriers in HIV care Read More »
Legislation to increase transparency of pharmacy benefit managers (PBMs), and to reauthorize the Pediatric Priority Review Voucher (PPRV), the Pandemic All Hazards Preparedness Act
Congress set to pass PBM reform and extensions of PPRV, PAHPA, Farm Bill Read More »
The Centers for Medicare & Medicaid Services (CMS) issued a directive telling private insurers providing Medicare Advantage (MA) plans to cover Biogen’s amyotrophic lateral sclerosis
CMS directs insurers to cover ALS drug Qalsody Read More »
Although illnesses like ulcerative colitis and Crohn’s disease are life-changing, gastrointestinal diseases are largely invisible, with little social recognition or understanding. For underserved communities
How COGI fights for policies to support BIPOC IBD patients Read More »
Proposed federal rules on exchange of medical data with China and five other “countries of concern” can protect Americans without obstructing the global flow
Data transfer rules don’t have to hamper biotech innovation, BIO says Read More »
Over 30 representatives from biodefense companies joined the Biotechnology Innovation Organization (BIO) on Capitol Hill in November to meet with bipartisan congressional leaders to
BIO hosts fly-in focused on biodefense, calls for PAHPA reauthorization Read More »
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
